carvedilol has been researched along with fluorobenzenes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, AL; Cleland, JG; Coletta, AP; Nikitin, NP | 1 |
| Ahn, JC; Kim, M; Kim, SH; Kim, YH; Lim, SY; Park, SM; Shim, WJ; Song, WH | 1 |
| Bowen, JP; Daphney, CM; Guner, OF; Moniri, NH; Murnane, KS; Murphy, TJ; Oppong-Damoah, A; Rambacher, KM; Rice, KC | 1 |
3 other study(ies) available for carvedilol and fluorobenzenes
| Article | Year |
|---|---|
Clinical trials update from the American College of Cardiology: Darbepoetin alfa, ASTEROID, UNIVERSE, paediatric carvedilol, UNLOAD and ICELAND.
Topics: Carbazoles; Carvedilol; Child; Cholesterol, LDL; Clinical Trials as Topic; Darbepoetin alfa; Diuretics; Erythropoietin; Fluorobenzenes; Heart Failure; Humans; Myocardial Infarction; Propanolamines; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ultrafiltration | 2006 |
Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats.
Topics: Animals; Antineoplastic Agents; Carbazoles; Cardiotonic Agents; Carvedilol; Doxorubicin; Echocardiography; Fluorobenzenes; Heart; Male; Oxidative Stress; Propanolamines; Pyrimidines; Rats; Rats, Sprague-Dawley; Rosuvastatin Calcium; Sulfonamides | 2012 |
The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo.
Topics: Adrenergic Antagonists; Amphetamines; Animals; Behavior, Animal; Binding Sites; Carvedilol; Computational Chemistry; Drug Discovery; Fluorobenzenes; HEK293 Cells; Humans; Lysergic Acid Diethylamide; Male; Mice; Models, Animal; Models, Molecular; Piperidines; Protein Binding; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Serotonin Receptor Agonists; Transfection | 2019 |